Discovery to Decision: Virtual Assays for Drug Target Ranking and Derisking Wednesday, 27th May 2026 AI investment trends and the opportunities in Alberta Tuesday, 14th Apr 2026 From Protocol to EDC in Minutes: How AI Is Rewriting Study Start-Up Tuesday, 24th Mar 2026 Decom: Delivering the next phase of value for oil and gas assets Thursday, 26th Mar 2026 Unlock value with MarketScan’s advanced data linking Thursday, 05th Mar 2026 - Tuesday, 27th Jan 2026 Future Proofing Cell & Gene Therapy: Strategies to Secure Your Leukapheresis Supply Chain Wednesday, 11th Mar 2026 From insight to implementation: live demo Thursday, 12th Feb 2026 De-Risking in Rare Kidney Disease Development: From Gene to Global Trial Execution Tuesday, 17th Feb 2026 Enabling the Next Generation of AI Data Centers: Delivering GW-Scale, AI-Ready Capacity Thursday, 26th Feb 2026 Canada Rising – The Next Frontier in Clinical Trials Tuesday, 20th Jan 2026 Posts navigation Older postsNewer posts
AI investment trends and the opportunities in Alberta Tuesday, 14th Apr 2026 From Protocol to EDC in Minutes: How AI Is Rewriting Study Start-Up Tuesday, 24th Mar 2026 Decom: Delivering the next phase of value for oil and gas assets Thursday, 26th Mar 2026 Unlock value with MarketScan’s advanced data linking Thursday, 05th Mar 2026 - Tuesday, 27th Jan 2026 Future Proofing Cell & Gene Therapy: Strategies to Secure Your Leukapheresis Supply Chain Wednesday, 11th Mar 2026 From insight to implementation: live demo Thursday, 12th Feb 2026 De-Risking in Rare Kidney Disease Development: From Gene to Global Trial Execution Tuesday, 17th Feb 2026 Enabling the Next Generation of AI Data Centers: Delivering GW-Scale, AI-Ready Capacity Thursday, 26th Feb 2026 Canada Rising – The Next Frontier in Clinical Trials Tuesday, 20th Jan 2026 Posts navigation Older postsNewer posts
From Protocol to EDC in Minutes: How AI Is Rewriting Study Start-Up Tuesday, 24th Mar 2026 Decom: Delivering the next phase of value for oil and gas assets Thursday, 26th Mar 2026 Unlock value with MarketScan’s advanced data linking Thursday, 05th Mar 2026 - Tuesday, 27th Jan 2026 Future Proofing Cell & Gene Therapy: Strategies to Secure Your Leukapheresis Supply Chain Wednesday, 11th Mar 2026 From insight to implementation: live demo Thursday, 12th Feb 2026 De-Risking in Rare Kidney Disease Development: From Gene to Global Trial Execution Tuesday, 17th Feb 2026 Enabling the Next Generation of AI Data Centers: Delivering GW-Scale, AI-Ready Capacity Thursday, 26th Feb 2026 Canada Rising – The Next Frontier in Clinical Trials Tuesday, 20th Jan 2026 Posts navigation Older postsNewer posts
Decom: Delivering the next phase of value for oil and gas assets Thursday, 26th Mar 2026 Unlock value with MarketScan’s advanced data linking Thursday, 05th Mar 2026 - Tuesday, 27th Jan 2026 Future Proofing Cell & Gene Therapy: Strategies to Secure Your Leukapheresis Supply Chain Wednesday, 11th Mar 2026 From insight to implementation: live demo Thursday, 12th Feb 2026 De-Risking in Rare Kidney Disease Development: From Gene to Global Trial Execution Tuesday, 17th Feb 2026 Enabling the Next Generation of AI Data Centers: Delivering GW-Scale, AI-Ready Capacity Thursday, 26th Feb 2026 Canada Rising – The Next Frontier in Clinical Trials Tuesday, 20th Jan 2026 Posts navigation Older postsNewer posts
Unlock value with MarketScan’s advanced data linking Thursday, 05th Mar 2026 - Tuesday, 27th Jan 2026 Future Proofing Cell & Gene Therapy: Strategies to Secure Your Leukapheresis Supply Chain Wednesday, 11th Mar 2026 From insight to implementation: live demo Thursday, 12th Feb 2026 De-Risking in Rare Kidney Disease Development: From Gene to Global Trial Execution Tuesday, 17th Feb 2026 Enabling the Next Generation of AI Data Centers: Delivering GW-Scale, AI-Ready Capacity Thursday, 26th Feb 2026 Canada Rising – The Next Frontier in Clinical Trials Tuesday, 20th Jan 2026 Posts navigation Older postsNewer posts
Future Proofing Cell & Gene Therapy: Strategies to Secure Your Leukapheresis Supply Chain Wednesday, 11th Mar 2026 From insight to implementation: live demo Thursday, 12th Feb 2026 De-Risking in Rare Kidney Disease Development: From Gene to Global Trial Execution Tuesday, 17th Feb 2026 Enabling the Next Generation of AI Data Centers: Delivering GW-Scale, AI-Ready Capacity Thursday, 26th Feb 2026 Canada Rising – The Next Frontier in Clinical Trials Tuesday, 20th Jan 2026 Posts navigation Older postsNewer posts
From insight to implementation: live demo Thursday, 12th Feb 2026 De-Risking in Rare Kidney Disease Development: From Gene to Global Trial Execution Tuesday, 17th Feb 2026 Enabling the Next Generation of AI Data Centers: Delivering GW-Scale, AI-Ready Capacity Thursday, 26th Feb 2026 Canada Rising – The Next Frontier in Clinical Trials Tuesday, 20th Jan 2026 Posts navigation Older postsNewer posts
De-Risking in Rare Kidney Disease Development: From Gene to Global Trial Execution Tuesday, 17th Feb 2026 Enabling the Next Generation of AI Data Centers: Delivering GW-Scale, AI-Ready Capacity Thursday, 26th Feb 2026 Canada Rising – The Next Frontier in Clinical Trials Tuesday, 20th Jan 2026 Posts navigation Older postsNewer posts
Enabling the Next Generation of AI Data Centers: Delivering GW-Scale, AI-Ready Capacity Thursday, 26th Feb 2026 Canada Rising – The Next Frontier in Clinical Trials Tuesday, 20th Jan 2026 Posts navigation Older postsNewer posts
Canada Rising – The Next Frontier in Clinical Trials Tuesday, 20th Jan 2026 Posts navigation Older postsNewer posts